Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

25F-NBOMe

From Wikipedia, the free encyclopedia

Pharmaceutical compound
25F-NBOMe
Clinical data
Other names2C-F-NBOMe; NBOMe-2C-F;N-(2-Methoxybenzyl)-4-fluoro-2,5-dimethoxyphenethylamine
Drug classSerotonin5-HT2 receptoragonist; Possibleserotonergic psychedelic; Possiblehallucinogen
ATC code
  • None
Identifiers
  • 2-(4-fluoro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
CAS Number
PubChemCID
Chemical and physical data
FormulaC18H22FNO3
Molar mass319.376 g·mol−1
3D model (JSmol)
  • COC1=CC=CC=C1CNCCC2=CC(=C(C=C2OC)F)OC
  • InChI=1S/C18H22FNO3/c1-21-16-7-5-4-6-14(16)12-20-9-8-13-10-18(23-3)15(19)11-17(13)22-2/h4-7,10-11,20H,8-9,12H2,1-3H3
  • Key:DFTJMIFNIHIWAJ-UHFFFAOYSA-N

25F-NBOMe, also known as2C-F-NBOMe orNBOMe-2C-F as well asN-(2-methoxybenzyl)-4-fluoro-2,5-dimethoxyphenethylamine, is aserotonin5-HT2 receptoragonist and possibleserotonergic psychedelic of thephenethylamine,2C, and25-NB (NBOMe) families.[1][2] It is the NBOMe (N-(2-methoxybenzyl))derivative of2C-F.[1][2]

25F-NBOMe activities
TargetAffinity (Ki, nM)
5-HT1AND
5-HT1B6,331
5-HT1D5,052
5-HT1END
5-HT1FND
5-HT2A3.3 (Ki)
16 (EC50Tooltip half-maximal effective concentration)
75% (EmaxTooltip maximal efficacy)
5-HT2B7.5 (Ki)
ND (EC50)
ND (Emax)
5-HT2C43 (Ki) (rat)
25 (EC50)
92% (
Emax)
5-HT3ND
5-HT4ND
5-HT5AND
5-HT680
5-HT7ND
α1Aα1DND
α2Aα2CND
β1β3ND
D1D5ND
H1H4ND
M1M5ND
I1ND
σ1,σ2ND
ORsND
TAAR1Tooltip Trace amine-associated receptor 1ND
SERTTooltip Serotonin transporterND (Ki)
ND (IC50Tooltip half-maximal inhibitory concentration)
ND (EC50)
NETTooltip Norepinephrine transporterND (Ki)
ND (IC50)
ND (EC50)
DATTooltip Dopamine transporterND (Ki)
ND (IC50)
ND (EC50)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs:[1][2]

Pharmacology

[edit]

Pharmacodynamics

[edit]

25F-NBOMe acts as apotent agonist of the serotonin5-HT2A and5-HT2C receptors and also shows interactions with certain othertargets, such as the serotonin5-HT2B receptor.[1][2] However, it shows more than an order of magnitude lower potency as a serotonin 5-HT2A receptor agonist than certain other NBOMe drugs like25I-NBOMe and25B-NBOMein vitro.[2]

History

[edit]

25F-NBOMe was first described in thescientific literature by 2010.[1]

See also

[edit]

References

[edit]
  1. ^abcdeHansen M (2010-12-16).Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain (Ph.D. thesis). University of Copenhagen.doi:10.13140/RG.2.2.33671.14245.
  2. ^abcdeHansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, et al. (March 2014)."Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists".ACS Chemical Neuroscience.5 (3):243–249.doi:10.1021/cn400216u.PMC 3963123.PMID 24397362.

External links

[edit]


Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=25F-NBOMe&oldid=1322818544"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp